1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To compare the efficacy and safety of treatment with dapagliflozin versus that with placebo add-on to saxagliptin plus metformin in patients whose type 2 diabetes is inadequately controlled with saxagliptin plus metformin treatment.

          Related collections

          Author and article information

          Journal
          Diabetes Care
          Diabetes care
          American Diabetes Association
          1935-5548
          0149-5992
          Nov 2015
          : 38
          : 11
          Affiliations
          [1 ] Katholieke Universiteit Leuven, Leuven, Belgium chantal.mathieu@med.kuleuven.be.
          [2 ] Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
          [3 ] Bristol-Myers Squibb, Princeton, NJ.
          [4 ] AstraZeneca, Molndal, Sweden.
          [5 ] AstraZeneca, Gaithersburg, MD.
          [6 ] MedImmune, Gaithersburg, MD.
          Article
          dc15-0779
          10.2337/dc15-0779
          26246458
          16b1d523-99de-45fc-a340-92818262c859
          History

          Comments

          Comment on this article